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Abstract
Background: Previously, we have developed and reported the method of measuring multi-walled carbon
nanotube (MWCNT) in the lung from rats exposed to MWCNT intratracheally. The present research was performed
to improve the analytical method of MWCNT to measure multiple samples in a short period of time. For the
analysis of MWCNTs from tissues, the existence of carbon black may interfere. Therefore, it was examined
whether or not carbon black interfere the determination of MWCNT in the standard solutions. Then, MWCNTs
were administered to rats and the MWCNTs were determined in the rats by the new method and the
recovery rates and time for determination were calculated. The standard solutions for MWCNTs and carbon
black were prepared, and the concentrations in the solutions were determined by HPLC with checking their
linearity between the concentrations and signal intensities. The reproducibility of the determination was also
checked.
Methods: The concentrations of MWCMTs in the standard solutions were determined by HPLC with a
fluorescent detector. Those of carbon black were also determined using the same method. The MWCNTs
were administered to rats intratracheally. The MWCNTs in the lung were determined in a newly modified
method including digestion of lung tissues by strong alkali solution and marking MWCNTs by
benzo[ghi]perylene. The time for the determinations was recorded and the recovery rate of MWVNTs was
calculated.
Results: MWCNT showed linearity in a range of 0.2 to 1.0 μg/mL. In contrast, carbon black demonstrated a
very low slope, showing flat pattern. Regarding the reproducibility of the analysis, the coefficient of variation
was lower than 10 %. The analysis of 20 samples were completed in 1.5 h. The recovery rates of MWCNT
from the lung of rats receiving intratracheal MWCNT administration were 101 to 102 %.
Conclusions: The improved method for measuring MWCNT allows an efficient MWCNT quantitation in a short
period of time. Also, a small amount of MWCNTs can be measured without influence of carbon black.
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Background
Recently, we have developed the analytical method of
multi-walled carbon nanotube (MWCNT) measurement
in the rat lung and reported the results obtained in the
experiments with MWCNT inhalation exposure and
intratracheal administration in rats [1]. This method was
also applied in rats which were subjected to 2-and 13-
weeks MWCNT exposure by inhalation [2, 3]. By the
method, the inter-animal variation was big and it took
2 h for the determination of 20 samples, which is a rela-
tively long period of time. Therefore, we developed a
new method that uses benzo[ghi]perylene (B(ghi)P) as a
marker which attached with MWCNTs. For the analysis
of MWCNTs from tissues, the existence of carbon black
may interfere. Therefore, it was examined whether or not
carbon black interfere the determination of MWCNT in
the standard solutions in a new method. Then, MWCNTs
were administered to rats and the MWCNTs were deter-
mined in the rats by the new method and the recovery
rates and time for determination were calculated.
Methods
Test substance
The MWCNT with an average width of 90.7 nm and
length of 5.7 μm was purchased from Hodogaya Chemical
Co. Ltd. (MWNT-7, Lot No. 080126, Tokyo, Japan).
Carbon black (CB) (JIS Test Powders 1 Class 12, Lot No.
2KA21) was purchased from The Association of Powder
Process Industry and Engineering (Kyoto, Japan), and the
particle diameter ranges were 30–200 nm.
These substances were used in the present study as
produced; i.e., without being purified or further sieved.
Since MWCNTs and CB are not water soluble, the test
substances were suspended in Clean99 K-200 (C99) as a
colloidal dispersant and subjected to ultrasonication for
30 min with an ultrasonic homogenizer (VP-30S,
20 kHz, 300 W, Taitec Co., Ltd., Tokyo, Japan).
Calibration curve
A 10-mg sample of MWCNT was added to 40 mL of
the TW-mixture and sonicated for 30 min. The solution
was diluted to 1 μg/mL with C99. This solution was
used to prepare additional standards of 0.2, 0.4, 0.6 and
0.8 μg/mL MWCNT in C99. The prepared solutions
were handled similarly “A newly developed method for
digestion of lung tissue and determination of MWCNTs”
following.
Animals and treatment
Male F344/DuCrlCrlj rats were purchased from Charles
River Japan, Inc. (Kanagawa, Japan) at the age of
12 weeks. The animals were quarantined, acclimated for
1 week, and then housed individually under controlled
environmental conditions. The room temperature in the
animal room was controlled at 23 °C ± 2 °C and the rela-
tive humidity at 55 % ± 15 % with 15 to 17 air changes/
hour. Fluorescent lighting was controlled automatically
to provide a 12-h light/dark cycle. All rats had free
access to sterilized water and γ-irradiation-sterilized
commercial pellet diet (CRF-1, Oriental Yeast Co., Ltd.,
Tokyo, Japan). This study was approved by the Animal
Experiment Committee of the Japan Bioassay Research
Center. Animal care was in accordance with the Guide-
lines for Proper Conduct of Animal Experiments (Science
Council of Japan, 2006).
Before the intratracheal administration, the ultrasoni-
cated suspension of MWCNT was further subjected
to additional ultrasonication for 30 s with a sonicator
(US-2, AS ONE Co., Ltd., Tokyo, Japan). Animals were 5
rats per group (total 10 rats) were used for the intratra-
cheal administration of MWCNT. Rats received
MWCNTs at a dose of 60 (Group A) and 120 μg/animal
(Group B). When starting the administration, the mean
body weights and standard deviations in Groups A and B
were 259 ± 10 g (5 rats) and 259 ± 11 g (5 rats), respect-
ively. After the inhalational anesthetization with the iso-
flurane gas (Forane, Abbott Japan Co., Ltd., Tokyo, Japan),
the 0.3 ml of suspension of MWCNT in 9.6 % phosphate-
buffered saline containing 0.1 % Tween 80 (TW-solution)
was intratracheally administered to rats using a micro-
spray cannula of an Intratracheal Aerosolizer (IA-1B,
PennCentury, Inc., USA). Rats were euthanized, and the
lungs and trachea were removed after 4 h of MWCNT
administration, weighed, and fixed in 10 % neutral
buffered formalin for 4 weeks. Then rat lungs were
assessed for MWCNTs quantities by the method de-
scribed below.
A newly developed method for digestion of lung tissue
and determination of MWCNTs
The lung samples were incubated with C99 at room
temperature overnight and were digested (Fig. 1a and b)
[4]. The digested solution of lungs by strong alkaline
was then centrifuged at 12,000 rpm for 10 min (Fig. 1c).
The supernatants were discarded and thereafter a 1 ml
of TW solution was added followed by stirring and fur-
ther centrifugation at 12,000 rpm for 10 min. Next, the
supernatants were discarded again and 200 μl of concen-
trated sulfuric acid was added to the precipitate (Fig. 1d).
The resultant solution was stirred and then, a 1 ml of
TW-solution was added and samples were sonicated
during a 10-s period. After adding 0.125 μg/ml B(ghi)P
and 50 μl acetonitrile, the solutions were stirred for
15 min (Fig. 1e) to produce MWCNT samples with ac-
tual concentrations of 0.2, 0.4, 0.6, 0.8, and 1.0 μg/ml.
Next, the MWCNTs adhering to Nuclepore membrane
filters (Whatman; 111109, pore size; 0.8 μm, diameter;
47 mm) was performed (Fig. 1f ). The filter with
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MWCNTs was then punched out in circular disks
with a 8 mm- diameter (Fig. 1g). The disc was soaked
in 1 ml of acetonitrile, and stirring. The attached
B(ghi)P with MWCNTs was extracted by acetonitrile
(Fig. 1h) and filtered before subjecting to the HPLC
analysis (Fig. 1i).
Chromatography was performed using an Acquity
UPLC system (Waters, Milford, MA, U.S.A.) coupled to
a fluorescence detector FLR (Waters). Eluates were
analyzed quantitatively by monitoring at fluorescent
wavelengths of 294 nm for excitation and 410 nm for
emission with 5 μl aliquots of extract injected onto a
1.7 μm C18 100 × 2.1 mm I.D. Acquity BEH column
(Waters) (Fig. 1i). The mobile phases were acetonitrile :
methanol : distilled water =75 : 20 : 5. The peak of the
injected sample was detected at about 1.3 min. An
eluent flow rate of 0.5 ml/min was used for all analyses.
The improved method was estimated to perform the
following three validations of calibration curve,
reproducibility and recovery
Validation 1. Calibration curve of MWCNT and CB
Using the improved method, 0.2, 0.4, 0.6, 0.8, and
1.0 μg/mL samples of MWCNT and CB were measured,
and the linearity was assessed.
Validation 2. Reproducibility of MWCNT
Twenty samples each of MWCNT at concentrations of
0.2 and 1.0 μg/mL were measured by the improved
method, and reproducibility was assessed.
Validation 3. Recovery of MWCNT administration in rat lung
MWCNT was intratracheally administered to rats (Group
A and Group B). Immediately after administration, rats
were subjected to autopsy. MWCNTs in the lung were
measured, and the dose and the volume of MWCNTs
were compared to assess the recovery rate.
Results
Calibration curve of MWCNT and CB
The calibration curves of MWCNT and CB are demon-
strated in Fig. 2. A positive correlation was found be-
tween the MWCNT concentration (0.2–1.0 μg/mL) and
the area value, showing a similar sensitivity to that of
our previous method [1]. The correlation coefficient and
p value were 0.9964 and 0.0000348. However, CB had a
Fig. 2 Calibration curves of MWCNT and CB
Fig. 1 A newly developed for MWCNT. a Lung tissue with the C99 at room temperature. b Lung digestion in C99. c Centrifugation of lung
solution at 12,000 rpm for 10 min. d Supernatant removal and 60 % sulfuric acid addition to MWCNT samples. e MWCNT-marker hybrid method:
Marker adsorbtion onto MWCNT for 15 min. f MWCNTs adhering to Nuclepore membrane filters were extracted with marker on MWCNTs. g Filter
with MWCNT was then punched out in circular disks h Addition of 1 ml acetonitrile, stirring, followed by the extraction of the marker in MWCNTs
and the acetonitrile filtration of marker in the MWCNTs. i HPLC analysis
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very low concentration-area slope, showing flat pattern,
and all relative intensity values determined by HPLC
were lower than the concentration of 0.2 μg/mL.
Reproducibility of MWCNT
Among the calibration curve samples, the concentra-
tions of 20 samples each for 0.2 and 1.0 μg/mL were de-
termined, and the results are shown in Table 1. The
measurement results were almost comparable to the
established solution concentrations, and the coefficient
of variation was less than 10 %, showing an acceptable
reproducibility for MWCNT analysis. The analysis of 20
samples completed in 1.5 h by reducing the number of
centrifugations from 4 to 2.
Recovery of MWCNT administration in rat lung
Immediately after the intratracheal MWCNT adminis-
tration to rats, the deposition amount in the lung was
measured. The results are shown in Table 2. While slight
fluctuations were seen among the 5 rats, quantity of
intratracheal administration of MWCNT and the quan-
tities of MWCNT in the lung (including the trachea)
were almost comparable.
Discussion
We developed the new method for analysis of very
small amount of MWCNT in lung [1]. In this report,
we investigated the effect of carbon black and the
shortening of the analysis time for the MWCNT. These
evaluation of the calibration curve revealed that select-
ive measurement of MWCNT is possible even in CB
coexistence conditions. The currently reported analyt-
ical procedures of MWCNT, such as carbon analysis
[5–7] and spectrophotometry [8], have difficulties in
the distribution between MWCNT and CB. This im-
proved method is the only one able to differentiate
MWCNT from CB.
Thorough diffusion of MWCNTs in the solution
using ultrasonic homogenizer immediately before add-
ing the marker, B(ghi)P, was important to suppress
fluctuations. Furthermore, the time required for the
analysis was shorter than 2 h by the previous method
[1], showing that the analysis can be completed in a
shorter period of time, which will lead to an increase
in the number of samples assayed in a certain period
of time.
These findings indicated that the present improved
method to measure the MWCNT can be applied for the
quantitation of its deposition in the lung.
Conclusions
The present improved method of MWCNT measure-
ment has the following benefits.
1) The improved method offers more efficiency as
compared to the previous one in case of MWCNT
quantitation in a short period of time (1.5 h for 20
samples).
2) Small amounts of MWCNTs could be measured
without the influence of CB.
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0.2 μg/mL 20 0.193 0.017 8.7
1.0 μg/mL 20 0.995 0.069 6.9






SD (μg/lung) Recovery (%)
60 μg 5 60.4 15.9 101
120 μg 5 122.3 36.3 102
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